{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:12:30Z","timestamp":1793657550328,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8025","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.1038\/s41586-024-07796-0","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:14:48Z","timestamp":1723032888000},"page":"686-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Dopamine reuptake and inhibitory mechanisms in human dopamine transporter"],"prefix":"10.1038","volume":"632","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-6032","authenticated-orcid":false,"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6190-0469","authenticated-orcid":false,"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinru","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-0733","authenticated-orcid":false,"given":"Yiqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-256X","authenticated-orcid":false,"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"7796_CR1","first-page":"490","volume":"11","author":"A Carlsson","year":"1959","unstructured":"Carlsson, A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11, 490\u2013493 (1959).","journal-title":"Pharmacol. Rev."},{"key":"7796_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1126\/science.2820058","volume":"237","author":"MC Ritz","year":"1987","unstructured":"Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219\u20131223 (1987).","journal-title":"Science"},{"key":"7796_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606\u2013612 (1996).","journal-title":"Nature"},{"key":"7796_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","volume":"152","author":"RG Nair-Roberts","year":"2008","unstructured":"Nair-Roberts, R. G. et al. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 152, 1024\u20131031 (2008).","journal-title":"Neuroscience"},{"key":"7796_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.55782\/ane-2007-1664","volume":"67","author":"O Arias-Carri\u00f3n","year":"2007","unstructured":"Arias-Carri\u00f3n, O. & P\u014fppel, E. Dopamine, learning, and reward-seeking behavior. Acta Neurobiol. Exp. 67, 481\u2013488 (2007).","journal-title":"Acta Neurobiol. Exp."},{"key":"7796_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nn.3413","volume":"16","author":"EE Steinberg","year":"2013","unstructured":"Steinberg, E. E. et al. A causal link between prediction errors, dopamine neurons and learning. Nat. Neurosci. 16, 966\u2013973 (2013).","journal-title":"Nat. Neurosci."},{"key":"7796_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0014-5793(91)81406-X","volume":"295","author":"B Giros","year":"1991","unstructured":"Giros, B., El Mestikawy, S., Bertrand, L. & Caron, M. G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149\u2013154 (1991).","journal-title":"FEBS Lett."},{"key":"7796_CR8","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","volume":"269","author":"H Gu","year":"1994","unstructured":"Gu, H., Wall, S. C. & Rudnick, G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124\u20137130 (1994).","journal-title":"J. Biol. Chem."},{"key":"7796_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1471-4159.1990.tb08847.x","volume":"55","author":"BK Krueger","year":"1990","unstructured":"Krueger, B. K. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55, 260\u2013267 (1990).","journal-title":"J. Neurochem."},{"key":"7796_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nature06133","volume":"449","author":"E Zomot","year":"2007","unstructured":"Zomot, E. et al. Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature 449, 726\u2013730 (2007).","journal-title":"Nature"},{"key":"7796_CR11","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1086\/302132","volume":"63","author":"ID Waldman","year":"1998","unstructured":"Waldman, I. D. et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767\u20131776 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"7796_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.pharmtox.43.050802.112309","volume":"43","author":"RR Gainetdinov","year":"2003","unstructured":"Gainetdinov, R. R. & Caron, M. G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43, 261\u2013284 (2003).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"7796_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer, D., Sonders, M. S., Poulsen, N. W. & Galli, A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406\u2013433 (2005).","journal-title":"Prog. Neurobiol."},{"key":"7796_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","volume":"38","author":"D Ciccarone","year":"2011","unstructured":"Ciccarone, D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim. Care 38, 41\u201358 (2011).","journal-title":"Prim. Care"},{"key":"7796_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.106950","volume":"120","author":"D Mustaquim","year":"2021","unstructured":"Mustaquim, D., Jones, C. M. & Compton, W. M. Trends and correlates of cocaine use among adults in the United States, 2006\u20132019. Addict. Behav. 120, 106950 (2021).","journal-title":"Addict. Behav."},{"key":"7796_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","volume":"14","author":"MJ Kuhar","year":"1991","unstructured":"Kuhar, M. J., Ritz, M. C. & Boja, J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299\u2013302 (1991).","journal-title":"Trends Neurosci."},{"key":"7796_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002130000616","volume":"154","author":"WL Woolverton","year":"2001","unstructured":"Woolverton, W. L., Hecht, G. S., Agoston, G. E., Katz, J. L. & Newman, A. H. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154, 375\u2013382 (2001).","journal-title":"Psychopharmacology"},{"key":"7796_CR18","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1021\/jm00041a002","volume":"37","author":"AH Newman","year":"1994","unstructured":"Newman, A. H., Allen, A. C., Izenwasser, S. & Katz, J. L. Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J. Med. Chem. 37, 2258\u20132261 (1994).","journal-title":"J. Med. Chem."},{"key":"7796_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","volume":"75","author":"RB Rothman","year":"2008","unstructured":"Rothman, R. B., Baumann, M. H., Prisinzano, T. E. & Newman, A. H. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem. Pharmacol. 75, 2\u201316 (2008).","journal-title":"Biochem. Pharmacol."},{"key":"7796_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","volume":"25","author":"RI Desai","year":"2005","unstructured":"Desai, R. I., Kopajtic, T. A., Koffarnus, M., Newman, A. H. & Katz, J. L. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J. Neurosci. 25, 1889\u20131893 (2005).","journal-title":"J. Neurosci."},{"key":"7796_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","volume":"162","author":"FJ Vocci","year":"2005","unstructured":"Vocci, F. J., Acri, Jane & Elkashef, A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 162, 1432\u20131440 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"7796_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.v59n1111","volume":"59","author":"J Biederman","year":"1998","unstructured":"Biederman, J. Attention-deficit\/hyperactivity disorder: a life-span perspective. J. Clin. Psychiatry 59, 4\u201316 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"7796_CR23","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00213-021-05946-0","volume":"238","author":"RR Jaeschke","year":"2021","unstructured":"Jaeschke, R. R., Sujkowska, E. & Sowa-Ku\u0107ma, M. Methylphenidate for attention-deficit\/hyperactivity disorder in adults: a narrative review. Psychopharmacology 238, 2667\u20132691 (2021).","journal-title":"Psychopharmacology"},{"key":"7796_CR24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","volume":"155","author":"ND Volkow","year":"1998","unstructured":"Volkow, N. D. et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155, 1325\u20131331 (1998).","journal-title":"Am. J. Psychiatry"},{"key":"7796_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0166-4328(97)00175-7","volume":"94","author":"MV Solanto","year":"1998","unstructured":"Solanto, M. V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94, 127\u2013152 (1998).","journal-title":"Behav. Brain Res."},{"key":"7796_CR26","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"ND Volkow","year":"2003","unstructured":"Volkow, N. D. & Swanson, J. M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160, 1909\u20131918 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"7796_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature12533","volume":"503","author":"A Penmatsa","year":"2013","unstructured":"Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85\u201390 (2013).","journal-title":"Nature"},{"key":"7796_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature14431","volume":"521","author":"KH Wang","year":"2015","unstructured":"Wang, K. H., Penmatsa, A. & Gouaux, E. Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322\u2013327 (2015).","journal-title":"Nature"},{"key":"7796_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41594-023-00983-z","volume":"30","author":"A Zhu","year":"2023","unstructured":"Zhu, A. et al. Molecular basis for substrate recognition and transport of human GABA transporter GAT1. Nat. Struct. Mol. Biol. 30, 1012\u20131022 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7796_CR30","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","volume":"187","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Transport mechanism and pharmacology of the human GlyT1. Cell 187, 1719\u20131732.e1714 (2024).","journal-title":"Cell"},{"key":"7796_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","volume":"569","author":"JA Coleman","year":"2019","unstructured":"Coleman, J. A. et al. Serotonin transporter\u2013ibogaine complexes illuminate mechanisms of inhibition and transport. Nature 569, 141\u2013145 (2019).","journal-title":"Nature"},{"key":"7796_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"7796_CR33","doi-asserted-by":"publisher","first-page":"21012","DOI":"10.1074\/jbc.M311972200","volume":"279","author":"LB Li","year":"2004","unstructured":"Li, L. B. et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012\u201321020 (2004).","journal-title":"J. Biol. Chem."},{"key":"7796_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mcn.2008.06.011","volume":"39","author":"E Boudanova","year":"2008","unstructured":"Boudanova, E., Navaroli, D. M., Stevens, Z. & Melikian, H. E. Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol. Cell. Neurosci. 39, 211\u2013217 (2008).","journal-title":"Mol. Cell. Neurosci."},{"key":"7796_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","volume":"51","author":"JU Fog","year":"2006","unstructured":"Fog, J. U. et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417\u2013429 (2006).","journal-title":"Neuron"},{"key":"7796_CR36","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1523\/JNEUROSCI.2649-11.2011","volume":"31","author":"DM Navaroli","year":"2011","unstructured":"Navaroli, D. M. et al. The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J. Neurosci. 31, 13758\u201313770 (2011).","journal-title":"J. Neurosci."},{"key":"7796_CR37","doi-asserted-by":"publisher","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","volume":"21","author":"ND Volkow","year":"2001","unstructured":"Volkow, N. D. et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21, RC121 (2001).","journal-title":"J. Neurosci."},{"key":"7796_CR38","doi-asserted-by":"publisher","first-page":"PL231","DOI":"10.1016\/0024-3205(96)00052-5","volume":"58","author":"SJ Gatley","year":"1996","unstructured":"Gatley, S. J., Pan, D., Chen, R., Chaturvedi, G. & Ding, Y.-S. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 58, PL231\u2013PL239 (1996).","journal-title":"Life Sci."},{"key":"7796_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0091-3057(91)90570-R","volume":"40","author":"RB Rothman","year":"1991","unstructured":"Rothman, R. B. et al. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40, 387\u2013397 (1991).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7796_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1471-4159.1987.tb05752.x","volume":"48","author":"PH Andersen","year":"1987","unstructured":"Andersen, P. H. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. Neurochem. 48, 1887\u20131896 (1987).","journal-title":"J. Neurochem."},{"key":"7796_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","volume":"166","author":"PH Andersen","year":"1989","unstructured":"Andersen, P. H. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493\u2013504 (1989).","journal-title":"Eur. J. Pharmacol."},{"key":"7796_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0014-2999(84)90483-7","volume":"103","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R. E. & Manzino, L. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103, 241\u2013248 (1984).","journal-title":"Eur. J. Pharmacol."},{"key":"7796_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","volume":"166","author":"PH Andersen","year":"1989","unstructured":"Andersen, P. H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493\u2013504 (1989).","journal-title":"Eur. J. Pharmacol."},{"key":"7796_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1124\/jpet.108.145813","volume":"329","author":"T Hiranita","year":"2009","unstructured":"Hiranita, T., Soto, P. L., Newman, A. H. & Katz, J. L. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J. Pharmacol. Exp. Ther. 329, 677\u2013686 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7796_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/jpet.110.171629","volume":"335","author":"TA Kopajtic","year":"2010","unstructured":"Kopajtic, T. A. et al. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. J. Pharmacol. Exp. Ther. 335, 703\u2013714 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7796_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.euroneuro.2010.03.005","volume":"20","author":"C Vel\u00e1zquez-S\u00e1nchez","year":"2010","unstructured":"Vel\u00e1zquez-S\u00e1nchez, C., Ferragud, A., Murga, J., Card\u00e1, M. & Canales, J. J. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. Eur. Neuropsychopharmacol. 20, 501\u2013508 (2010).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"7796_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1124\/jpet.103.060525","volume":"309","author":"JL Katz","year":"2004","unstructured":"Katz, J. L., Kopajtic, T. A., Agoston, G. E. & Newman, A. H. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J. Pharmacol. Exp. Ther. 309, 650\u2013660 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7796_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","volume":"60","author":"H Bisgaard","year":"2011","unstructured":"Bisgaard, H. et al. The binding sites for benztropines and dopamine in the dopamine transporter overlap. Neuropharmacology 60, 182\u2013190 (2011).","journal-title":"Neuropharmacology"},{"key":"7796_CR49","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nn.2146","volume":"11","author":"T Beuming","year":"2008","unstructured":"Beuming, T. et al. The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780\u2013789 (2008).","journal-title":"Nat. Neurosci."},{"key":"7796_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114204120","volume":"120","author":"M Niello","year":"2023","unstructured":"Niello, M. et al. Persistent binding at dopamine transporters determines sustained psychostimulant effects. Proc. Natl Acad. Sci. USA 120, e2114204120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7796_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.105.091231","volume":"315","author":"RI Desai","year":"2005","unstructured":"Desai, R. I., Kopajtic, T. A., French, D., Newman, A. H. & Katz, J. L. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. J. Pharmacol. Exp. Ther. 315, 397\u2013404 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7796_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuropharm.2005.08.011","volume":"49","author":"BK Gorentla","year":"2005","unstructured":"Gorentla, B. K. & Vaughan, R. A. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology 49, 759\u2013768 (2005).","journal-title":"Neuropharmacology"},{"key":"7796_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"7796_CR54","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"7796_CR55","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"7796_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"7796_CR57","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"7796_CR58","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"7796_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07796-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T03:09:34Z","timestamp":1723691374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":59,"journal-issue":{"issue":"8025","published-print":{"date-parts":[[2024,8,15]]}},"alternative-id":["7796"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-07796-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}